Fenbendazole
Benzimidazole AnthelminticGeneric Name: Fenbendazole
Generic Name: Fenbendazole
Any application of Fenbendazole in oncological protocols must be conducted strictly under the supervision of a Vitalix specialist. Self-administration without professional guidance is not recommended.
Fenbendazole is a powerful microtubule-disrupting agent that Vitalix utilizes for its ability to selectively target cancer cell metabolism. By inhibiting glucose uptake in malignant cells and inducing oxidative stress, Fenbendazole creates a hostile environment for tumor progression. We have documented numerous cases where it complements standard therapies, particularly in refractory cancers.
A benzimidazole anthelmintic (methyl N-(6-phenylsulfanyl-1H-benzimidazol-2-yl)carbamate) formulated for optimal bioavailability in human clinical applications.
Generally well-tolerated. Potential for mild, reversible liver enzyme elevation. Regular clinical assessment is mandatory.
Known hypersensitivity to benzimidazoles. Use with caution in patients with pre-existing hepatic impairment.
Minimal known interactions with standard oncological agents, but professional coordination is essential to ensure synergy.
Discuss how these medications might fit into your personalized cancer treatment protocol with our specialists.
$1,000 starting
Consultations start from $1,000